Yes — trials show Wegovy users lose more weight earlier than with Saxenda, thanks to its stronger appetite effect and weekly dosing. That said, both require steady use over months for results to build. The two medicines at a glance Wegovy and Saxenda belong to the same family of medicines, GLP-1 receptor agonists. They help people feel fuller sooner, reduce appetite, and support healthier eating. The difference lies in the active ingredient and how they are dosed: Wegovy cont

In many cases, Wegovy can be used as the main weight loss medicine, especially when diet and exercise alone haven’t worked. However, switching or replacing other drugs should always be guided by a clinician, as some combinations may still be appropriate depending on health needs. Wegovy as a first-choice option Since its approval by NICE in 2023, Wegovy (semaglutide 2.4 mg weekly) has become the leading option for medical weight management in the UK. Clinical evidence from th

Both Wegovy (semaglutide 2.4 mg) and Trulicity (dulaglutide) improve blood sugar, but semaglutide generally produces greater reductions in HbA1c and body weight. NICE recommends semaglutide more widely for people needing weight-focused management. Two GLP-1 medicines, one key difference Wegovy and Trulicity both belong to the GLP-1 receptor agonist family of medicines. They mimic the hormone GLP-1, which reduces appetite, slows digestion, and stimulates insulin release when b

Wegovy is taken once weekly via an injection pen, with doses stepped up over 16 weeks. Saxenda requires a daily injection, Mounjaro is a...

Since both contain semaglutide, their side-effect profiles are similar — most commonly nausea, vomiting, and diarrhoea. Wegovy uses a...

In major STEP trials, Wegovy led to about 15% weight loss over 68 weeks. Contrave (called Mysimba in the UK) generally achieves around 6–9% across pivotal studies. This means semaglutide tends to provide greater weight reduction than naltrexone/bupropion combinations. Two very different approaches Although both Wegovy and Contrave are prescribed for weight management, they work in completely different ways. Wegovy contains semaglutide, a GLP-1 receptor agonist that reduces ap

Wegovy was developed by Novo Nordisk as a higher-dose formulation of the GLP-1 receptor agonist semaglutide for chronic weight management, building on earlier experience with semaglutide for type 2 diabetes. Its evidence base comes from large, international STEP trials focused on weight and related health markers, with additional research exploring cardiovascular and kidney outcomes in selected groups. UK adoption is guided by national appraisals and commissioning policies; S

Combination weight loss medications aren’t routine in UK services because evidence for stacking treatments is limited and side-effect...

If you’ve ever popped into your local pharmacy for more than just a prescription—maybe for a blood pressure check, flu jab, or even a...

Are you considering Wegovy to help with your weight loss journey? You've made a promising choice! Wegovy is gaining attention for its effectiveness, especially for people struggling to lose weight through diet and exercise alone. In this blog, we'll walk you through how to start on Wegovy in the UK, from understanding the process of obtaining a prescription to what criteria you must meet and how to get the most out of your healthcare consultations. Let's get started on this p

The journey to successful weight loss is often guided by the expertise of healthcare providers. Their insights and recommendations can be...

If you’re exploring Wegovy (semaglutide) as a treatment option for weight management, understanding the prescription process is essential...

If you're considering Wegovy (semaglutide) for weight management, you might have noticed that the cost can be quite high, posing a...

Navigating the process of obtaining weight loss medications can be overwhelming, especially when seeking options through the NHS. Wegovy (semaglutide), recently approved for weight management in the UK, has garnered substantial interest due to its efficacy. Understanding how to obtain Wegovy through the NHS is critical for accessibility. This guide offers a step-by-step approach, outlines eligibility criteria, and shares patient experiences to help you through the process. Le

Mounjaro , with the active ingredient tirzepatide, is a recently approved medication for weight management and type 2 diabetes in the UK....

Mounjaro , known scientifically as tirzepatide, has recently made waves in the medical community with its authorization for weight...